Target intelligence / Profile preview

Antimutagenic

Molecular classification
Other
01

Overview

"Antimutagenic" is not a single molecule or receptor but rather a functional property describing agents—both natural and synthetic—that reduce the frequency or impact of mutations caused by mutagens. These agents can act through various mechanisms such as antioxidant activity, inhibition or inactivation of mutagens before they interact with genetic material, enhancement of cellular DNA repair processes, and induction of cell death in mutated cells. Examples include certain vitamins, minerals like selenium and magnesium, carotenoids, flavonoids, and other micronutrients. The term "antimutagenic" is therefore descriptive for a class or function rather than denoting any specific molecular target suitable for structured drug-target databases.

Other names
Antimutagenantimutagenic agentantimutagenic compound
02

Mechanism of action

Antioxidant activity (scavenging free radicals and reactive oxygen species); Inhibition of mutagen activation or interaction with DNA; Enhancement of DNA repair pathways (e.g., base excision repair, nucleotide excision repair); Induction of programmed cell death in damaged cells

03

Biological functions

Prevention of DNA mutationEnhancement of DNA repairInactivation or blocking of mutagens
04

Disease associations

Cancer (chemoprevention)Other (general protection against mutagen-induced diseases)
05

Safety considerations

No specific safety concerns are associated with the concept "antimutagenic" itself; safety would depend on the individual compound used.
06

Interacting drugs

Carotenoids

4 more in the full profile.

Beyond the preview

Go deeper on Antimutagenic.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Antimutagenic.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call